CAS: 1609281-86-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | AZD3264 REF: AN-AG00ABN0CAS: 1609281-86-8 | 98% | 458,00 €~1.074,00 € | Jue 02 May 24 |
 | AZD3264 REF: TM-T6771CAS: 1609281-86-8 | 99.42% | 52,00 €~1.569,00 € | Jue 09 May 24 |
 | AZD3264 REF: 3D-JPC28186CAS: 1609281-86-8 | Min. 95% | A consultar | Jue 13 Jun 24 |
Ref: AN-AG00ABN0
| 10mg | 458,00 € | |
| 25mg | 666,00 € | |
| 50mg | 1.074,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
AZD3264
CAS:1609281-86-8
AZD3264 is a new type IKK2 inhibitor.
Fórmula:
C21H23N5O4S
Pureza:
99.42%
Forma y color:
Solid
Peso molecular:
441.5
Ref: TM-T6771
| 1mg | 52,00 € | |
| 2mg | 69,00 € | |
| 5mg | 102,00 € | |
| 10mg | 157,00 € | |
| 25mg | 307,00 € | |
| 50mg | 491,00 € | |
| 100mg | 787,00 € | |
| 500mg | 1.569,00 € | |
| 1ml*10 (DMSO) | 112,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
AZD3264
CAS:1609281-86-8
AZD3264 is a matrix effect-based drug candidate that is currently being studied for its potential …
Fórmula:
C21H23N5O4S
Pureza:
Min. 95%
Peso molecular:
441.5 g/mol
Ref: 3D-JPC28186
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
